HWAM
NUVB icon

Hennion & Walsh Asset Management’s Nuvation Bio NUVB Stock Holding History

Hennion & Walsh Asset Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.54M Buy
453,143
+6,458
+1% +$40.5K 0.07% 316
2026
Q2 		$2.54M Sell
446,685
-3,909
-0.9% -$19.1K 0.07% 327
2026
Q1 		$1.93M Buy
450,594
+5,315
+1% +$29.6K 0.07% 362
2025
Q4 		$3.99M Buy
445,279
+106,008
+31% +$657K 0.14% 187
2025
Q3 		$1.26M Buy
339,271
+139,633
+70% +$381K 0.05% 459
2025
Q2 		$389K Buy
+199,638
New +$416K 0.02% 751

Other funds holding NUVB

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
HCA
Harbour Capital Advisors Tysons Corner, Virginia $548M AUM 37.76% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
FWP
Firethorn Wealth Partners Augusta, Georgia $313M AUM 15.55% 1-Year Est. Return
EWA
Emergent Wealth Advisors Williamsville, New York $191M AUM 17.3% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Hennion & Walsh Asset Management's NUVB Position: Q3 2026 in Review

Hennion & Walsh Asset Management increased its Nuvation Bio (NUVB) stake by 1.4% in Q3 2026, buying an estimated $40.5K and bringing the position to 453,143 shares worth $2.54M. The position accounts for 0.07% of the portfolio, ranked #316.

Hennion & Walsh Asset Management first reported a position in NUVB in Q2 2025 and has held it in 6 quarters since. The position peaked at $3.99M in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • Hennion & Walsh Asset Management held 453,143 shares of Nuvation Bio worth $2.54M as of Q3 2026.
  • Hennion & Walsh Asset Management bought 6,458 Nuvation Bio shares in Q3 2026, an estimated $40.5K.
  • Nuvation Bio made up 0.07% of Hennion & Walsh Asset Management's portfolio in Q3 2026, its #316 holding.
  • Hennion & Walsh Asset Management first reported a position in Nuvation Bio in Q2 2025 and has held it in 6 quarters since.
  • Hennion & Walsh Asset Management's Nuvation Bio position peaked at $3.99M in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2026, filed 13 Oct 2026.